CA2006184A1 - Compose a liberation prolongee a base de trimebutine et procede de preparation - Google Patents

Compose a liberation prolongee a base de trimebutine et procede de preparation

Info

Publication number
CA2006184A1
CA2006184A1 CA2006184A CA2006184A CA2006184A1 CA 2006184 A1 CA2006184 A1 CA 2006184A1 CA 2006184 A CA2006184 A CA 2006184A CA 2006184 A CA2006184 A CA 2006184A CA 2006184 A1 CA2006184 A1 CA 2006184A1
Authority
CA
Canada
Prior art keywords
trimebutine
preparation
composition based
release composition
prolonged release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2006184A
Other languages
English (en)
Other versions
CA2006184C (fr
Inventor
Loufty Omar Benkerrour
Francoise Chanoine
Jacques Sylvain Frances
Jean-Louis Junien
Gilbert Aubard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jouveinal SA
Original Assignee
Jouveinal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal SA filed Critical Jouveinal SA
Publication of CA2006184A1 publication Critical patent/CA2006184A1/fr
Application granted granted Critical
Publication of CA2006184C publication Critical patent/CA2006184C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002006184A 1988-12-28 1989-12-20 Compose a liberation prolongee a base de trimebutine et procede de preparation Expired - Lifetime CA2006184C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8817303A FR2640876B1 (fr) 1988-12-28 1988-12-28
FR8817303 1988-12-28

Publications (2)

Publication Number Publication Date
CA2006184A1 true CA2006184A1 (fr) 1990-06-28
CA2006184C CA2006184C (fr) 1999-11-23

Family

ID=9373520

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006184A Expired - Lifetime CA2006184C (fr) 1988-12-28 1989-12-20 Compose a liberation prolongee a base de trimebutine et procede de preparation

Country Status (14)

Country Link
JP (1) JP2745232B2 (fr)
KR (1) KR0137270B1 (fr)
AT (1) AT397461B (fr)
BE (1) BE1006002A4 (fr)
CA (1) CA2006184C (fr)
DE (1) DE3942131C2 (fr)
EG (1) EG19994A (fr)
ES (1) ES2019024A6 (fr)
FR (1) FR2640876B1 (fr)
GR (1) GR1000429B (fr)
GT (1) GT198900080A (fr)
IT (1) IT1236239B (fr)
MX (1) MX170641B (fr)
PT (1) PT92682B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05255125A (ja) * 1992-02-29 1993-10-05 Upjohn Co:The 徐放性製剤およびその製法
FR2730163B1 (fr) * 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
KR101051630B1 (ko) * 2008-10-02 2011-07-26 한국유나이티드제약 주식회사 용출률과 복용편의성이 향상된 트리메부틴 서방정
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
IT8912615A0 (it) 1989-12-20
KR900009060A (ko) 1990-07-02
FR2640876B1 (fr) 1993-09-24
PT92682B (pt) 1997-01-31
GR1000429B (el) 1992-07-30
DE3942131A1 (de) 1990-07-05
PT92682A (pt) 1990-06-29
IT8912615A1 (it) 1991-06-20
JP2745232B2 (ja) 1998-04-28
ATA294489A (de) 1993-09-15
KR0137270B1 (ko) 1998-04-25
JPH02184624A (ja) 1990-07-19
DE3942131C2 (de) 1998-09-17
ES2019024A6 (es) 1991-05-16
GT198900080A (es) 1991-06-20
AT397461B (de) 1994-04-25
IT1236239B (it) 1993-01-27
BE1006002A4 (fr) 1994-04-19
GR890100860A (en) 1991-03-15
CA2006184C (fr) 1999-11-23
FR2640876A1 (fr) 1990-06-29
EG19994A (en) 1997-01-30
MX170641B (es) 1993-09-01

Similar Documents

Publication Publication Date Title
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
HUT61031A (en) Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient
CA2117351A1 (fr) Methode de fabrication permettant d'accroitre la durete des comprimes
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
CA2190882A1 (fr) Preparation de compositions de principe actif sous forme de solution solide dudit principe actif dans une matrice polymere et preparations de principe actif obtenues a l'aide dudit procede
CA2161103A1 (fr) Formulations d'oxybutynine a liberation regulee
CA2066248A1 (fr) Esters d'acides thiophenecarboxyliques et d'aminoalcools; composes quaternaires obtenus par cette voie; production et utilisation de ces substances
CA2154424A1 (fr) 1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
EP0300189A3 (en) New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA2166483A1 (fr) Nouvelle formulation pharmaceutique
CA2171844A1 (fr) Formulations de liberation prolongee de metoprolol pendant 24 heures
CA2087435A1 (fr) Utilisation de membranes a polymerisation interfaciale dans des medicaments a liberation controlee
CA2126091A1 (fr) Nouveaux polypeptides biologiquement actifs, leur preparation et composition pharmaceutique les contenant
CA2170647A1 (fr) Forme posologique sous forme de comprime composite (i)
IE881916L (en) Press-coated dihydropyridine tablets
CA2172616A1 (fr) Tropyl 7-azaindol-3-ylcarboxamides, antitussifs
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2152615A1 (fr) Compositions pharmaceutiques a base d'atovaquone
CA2093666A1 (fr) Preparation pharmaceutique sans solvant pour administration par voie orale permettant une liberation prolongee de l'ingredient actif et methode de fabrication de ladite preparation
AU5221890A (en) 4(3h)-pteridinones, preparation processes and drugs containing them
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
CA2017851A1 (fr) Particules biodegradables micronisees; methode de preparation et utilisation
CA2037569A1 (fr) Formule a liberation reglee
IL85139A0 (en) Polymer complexes,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2097044A1 (fr) Acides a groupement cyclopentane- et pentene-.beta.-amino

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry